382
Views
7
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care

, , &
Pages 99-108 | Received 12 Jun 2009, Accepted 11 Aug 2009, Published online: 01 Feb 2010

References

  • Suvisaari T, Hakkinen L, Haukka J, Lonnquist J. Mortality in offspring of mothers with psychotic disorders. Psychol Med 2008; 38:1203–1210.
  • Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79–91.
  • Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Pre-term birth and intra-uterine growth retardation among children of mothers with schizophrenia. Br J Psychiatry 1999; 175:239–245.
  • Nilsson E, Hultman CM, Cnattingius S, Olausson PO, Bjork C, Lichtenstein P. Schizophrenia and offspring's risk for adverse pregnancy outcomes and infant death. Br J Psychiatry 2008; 193:311–315.
  • Holmes LB, Harvey EA, Coull BA . The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344:1132–1138.
  • Iqbal MM, Sohhan T, Mahmud SZ. The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J Toxicol Clin Toxicol 2001; 39:381–392.
  • Jager-Roman E, Deichl A, Jakob S . Fet al growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108:997–1004.
  • Morrow J, Russell A, Guthrie E . Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193–198.
  • Viguera AC, Whitfield T, Baldessarini RJ . Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817–1824; quiz 923.
  • Mercy Health and Aged Care. Psychotropic medication in pregnancy and lactation. Melbourne: MH&AC Publication, 2007.
  • Berk M, Jacka FN, Williams LJ, Ng F, Dodd S, Pasco JA. Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample. Aust N Z J Psychiatry 2008; 42:874–878.
  • Eyles DW, Cui X, Kesby JP . Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009 June 4 [Epub ahead of print].
  • Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266–281.
  • Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 2008; 34:1054–1063.
  • Yonkers KA, Wisner KL, Stowe Z . Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608–620.
  • McKenna K, Koren G, Tetelbaum M . Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66:444–449.
  • Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009; 15:183–192.
  • Vajda FJ, Hitchcock A, Graham J, O'Brien T, Lander C, Eadie M. The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468–474.
  • Walker SP, Permezel M, Berkovic SF. The management of epilepsy in pregnancy. BJOG 2009; 116:758–767.
  • Omtzigt JG, Los FJ, Grobbee DE . The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992; 42(Suppl 5):119–125.
  • Rodriguez-Pinilla E, Arroyo I, Fondevilla J, Garcia MJ, Martinez-Frias ML. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. Am J Med Genet 2000; 90:376–381.
  • Meador KJ, Baker GA, Browning N . Cognitive function at 3 years of age after fet al exposure to antiepileptic drugs. N Engl J Med 2009; 360:1597–1605.
  • Adab N, Kini U, Vinten J . The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75:1575–1583.
  • Eriksson K, Viinikainen K, Monkkonen A . Children exposed to valproate in utero: population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005; 65:189–200.
  • Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, Steinhausen H-C. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117–122.
  • Viinikainen K, Eriksson K, Monkkonen A . The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy Behav 2006; 9:636–640.
  • Jacobson SJ, Jones K, Johnson K . Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339(8792):530–533.
  • Weinstein MR. The international register of lithium babies. Drug Inf J 1976; 10:94–100.
  • Kallen B, Tandberg A. Lithium and pregnancy. A cohort study on manic-depression. Acta Psychiatr Scand 1983; 68:134–139.
  • Cohen L, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A re-evaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146–150.
  • Llewellyn A, Stowe ZN, Strader JRJr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998; 59(Suppl 6):57–64; discussion 5.
  • Nguyen HTT, Sharma V, McIntyre RS. Teratogenesis associated with antibipolar drugs. Adv Ther 2009; 26:281–294.
  • Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord 2006; 8:207–220.
  • Souka AP, von Kaisenberg CS, Hyett JA. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192:1005–1021.
  • Dashe JS, Twickler DM, Santos-Ramos R, McIntire DD, Ramos RM. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound. Am J Obstet Gynecol 2006; 195:1623–1628.
  • Patsalos PN, Berry D, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI. Antiepileptic drugs: best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILEA Commission on Therapeutic Strategies. Epilepsia 2008; 49:1239–1276.
  • Newham JJ, Thomas SH, MacRitchie K, McElhatten PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008; 192:333–337.
  • NICE. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. National Institute for Health and Clinical Excellence: London, 2004. [cited 30th May 2009.] Available from URL: http://www.nice.org.uk/CG020NICEguideline
  • Newport DJ, Viguera AC, Beech AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162:2162–2170.
  • Hale T. Medications and mothers’ milk, 11th. Amarillo: Pharmasoft Medical Publishing, 2004.
  • Viguera AC, Newport DJ, Ritchie J . Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007; 164:342–345.
  • Gentile S. Infant safety with antipsychotic therapy in breast feeding: a systematic review. J Clin Psychiatry 2008; 69:666–673.
  • Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179–184.
  • Davies A, McIvor RJ, Kumar RC. Impact of childbirth on a series of schizophrenic mothers: a comment on the possible influence of oestrogen on schizophrenia. Schizophr Res 1995; 16:25–31.
  • Riordan D, Appleby L, Faragher B. Mother-infant interaction in post-partum women with schizophrenia and affective disorders. PsycholMed 1999; 29:991–995.
  • Snellen M, Mack K, Trauer T. Schizophrenia, mental state, and mother-infant interaction: examining the relationship. Aust N Z J Psychiatry 1999; 33:902–911.
  • Wan MW, Salmon MP, Riordan DM, Appelby L, Webb R, Abel KM. What predicts poor mother-infant interaction in schizophrenia? Psychol Med 2007; 37:537–546.
  • Sroufe LA, Egeland B, Carlson EA, Collins WA. The development of the person: The Minnesota Study of Risk and Adaptation from Birth to Adulthood. New York: Guilford Press, 2005.
  • Wan MW, Moulton S, Abel KM. A review of mother-child relational interventions and their usefulness for mothers with schizophrenia. Arch Womens Ments Health 2008; 11:171–179.
  • Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM. Prophylactic lithium in puerperal psychosis. Br J Psychiatry 1991; 158:393–397.
  • Yatham LN, Kennedy SH, Schaffer A . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11:225–255.
  • Henshaw SK. Unintended pregnancy in the United States. Fam Plan Perspect 1998; 30:24–29.
  • Coverdale J, Falloon I, Turbott S. Sexually transmitted disease and family planning counselling of psychiatric patients in New Zealand. Aust N Z J Psychiatry 1997; 31:285–290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.